EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023

Huiwen Liu, Jiazi Zhou, Hong Liu, Depei Wu iD

Cancers · 30.07.2026 · 18 (15) · 2449

DOI: 10.3390/cancers18152449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 30.07.2026. Verfasst von Huiwen Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Hematologic Diseases, Jiangsu Key Laboratory of Hematologic Diseases, Jiangsu Institute of Hematology, The Firs…. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Jiangsu Provincial Medical Innovation Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multiple myeloma (MM) is a malignant plasma cell disorder associated with substantial mortality and long-term disability. With rapid population aging in China, its disease burden may be increasing, yet comprehensive long-term assessments remain limited.

Methods

Using data from the Global Burden of Disease Study 2023, we evaluated trends in prevalence, incidence, deaths, and disability-adjusted life years (DALYs) of MM in China from 1990 to 2023. Age-standardized rates were analyzed using Joinpoint regression to estimate temporal trends.

Results

Between 1990 and 2023, prevalence, incidence, deaths, and DALYs of MM increased markedly in China, with consistent upward trends in age-standardized rates. The burden was concentrated among older adults and was higher in males than females. Decomposition analysis showed that epidemiological changes were the primary driver of increased DALYs and deaths. Forecasting analyses suggest that although age-standardized mortality and DALY rates may gradually decline, the absolute number of deaths is expected to continue rising.

Conclusions

The burden of MM in China has increased substantially over the past three decades and is projected to remain high. Strengthening early detection, risk-oriented prevention, and long-term management strategies is essential to mitigate future disease burden.

Schlagwörter

Stichwörter der Autor:innen

DALYsdecomposition analysisepidemiological changeglobal burden of diseasemultiple myelomatrends

Autor:innen und Institutionen

  • National Clinical Research Center for Hematologic Diseases, Jiangsu Key Laboratory of Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.

ORCID-Profile: Depei Wu

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Jiangsu Provincial Medical Innovation Center
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Liu, H., Zhou, J., Liu, H., & Wu, D. (2026). Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023. Cancers, 18(15), 2449. https://doi.org/10.3390/cancers18152449

Vancouver

Liu H, Zhou J, Liu H, Wu D. Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023. Cancers. 2026;18(15):2449. doi:10.3390/cancers18152449

BibTeX
@article{Liu2026,
  author = {Liu, Huiwen and Zhou, Jiazi and Liu, Hong and Wu, Depei},
  title = {Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {2449},
  doi = {10.3390/cancers18152449}
}
Kostenlos starten →